Hybridomas Segment to Register Highest CAGR in Cell Line Development Market during 2020-2027
According to this latest study on “Cell Line Development Market Forecast to 2027 - COVID-19 Impact and Analysis - by Type, Product, and Application,” the market was valued at US$ 4,160.42 million in 2019 and is projected to reach US$ 11,219.87 million by 2027; it is expected to grow at a CAGR of 13.3% from 2020 to 2027. The report highlights trends prevailing in the global cell line development market, and the drivers and restraints pertaining to the market growth.
The global cell line development market, based on type, is segmented into primary cell line, hybridomas, continuous cell lines, and recombinant cell lines. The recombinant cell lines segment held the largest share of the market in 2019. This growth is ascribed to the increasing demand for recombinant cell lines in the production of therapeutic recombinant proteins. However, the hybridomas segment is estimated to register the highest CAGR during the forecast period. This growth is attributed to rising research and development activities for novel biologics.
Stable cell lines are widely used in a wide range application, including biologics production, drug screening, and gene functional studies. The COVID-19 pandemic led to disruptions in all phases of drug development, and it has compelled many pharmaceutical companies and clinical research organizations (CROs) to put their clinical studies on hold. The new government policies, stay-at-home orders, social distancing norms, and widespread anxiety are among the prime challenges faced by researchers conducting the ongoing studies.
The growth of the cell line development market is attributed to factors such as increasing adoption of regenerative medicines, rising prevalence of cancer in the world, and mounting investments in R&D by pharmaceutical and biotechnology companies. However, the risks associated with cell line contamination hinder the growth of this market. Merck KGaA, Thermo Fisher Scientific Inc., Selexis SA (JSR Corporation), BioFactura, Inc., Corning Incorporated, Sartorius AG, Lonza, GENERAL ELECTRIC, LakePharma, Inc., and WuXiAppTec Group are among the leading companies operating in the global cell line development market.
The Report Segments Global Cell Line Development Market as Follows:
By Type
By Product
By Application
By Geography
North America
Europe
Asia Pacific (APAC)
Middle East and Africa (MEA)
Reasons to Buy
According to this latest study on “Cell Line Development Market Forecast to 2027 - COVID-19 Impact and Analysis - by Type, Product, and Application,” the market was valued at US$ 4,160.42 million in 2019 and is projected to reach US$ 11,219.87 million by 2027; it is expected to grow at a CAGR of 13.3% from 2020 to 2027. The report highlights trends prevailing in the global cell line development market, and the drivers and restraints pertaining to the market growth.
The global cell line development market, based on type, is segmented into primary cell line, hybridomas, continuous cell lines, and recombinant cell lines. The recombinant cell lines segment held the largest share of the market in 2019. This growth is ascribed to the increasing demand for recombinant cell lines in the production of therapeutic recombinant proteins. However, the hybridomas segment is estimated to register the highest CAGR during the forecast period. This growth is attributed to rising research and development activities for novel biologics.
Stable cell lines are widely used in a wide range application, including biologics production, drug screening, and gene functional studies. The COVID-19 pandemic led to disruptions in all phases of drug development, and it has compelled many pharmaceutical companies and clinical research organizations (CROs) to put their clinical studies on hold. The new government policies, stay-at-home orders, social distancing norms, and widespread anxiety are among the prime challenges faced by researchers conducting the ongoing studies.
The growth of the cell line development market is attributed to factors such as increasing adoption of regenerative medicines, rising prevalence of cancer in the world, and mounting investments in R&D by pharmaceutical and biotechnology companies. However, the risks associated with cell line contamination hinder the growth of this market. Merck KGaA, Thermo Fisher Scientific Inc., Selexis SA (JSR Corporation), BioFactura, Inc., Corning Incorporated, Sartorius AG, Lonza, GENERAL ELECTRIC, LakePharma, Inc., and WuXiAppTec Group are among the leading companies operating in the global cell line development market.
The Report Segments Global Cell Line Development Market as Follows:
By Type
- Primary Cell Line
- Hybridomas
- Continuous Cell Lines
- Recombinant Cell Line
By Product
- Equipment
- Media & Reagent
By Application
- Drug Discovery
- Bioproduction
- Tissue Engineering
By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
- Rest of APAC
Middle East and Africa (MEA)
- Saudi Arabia
- UAE
- South Africa
- Rest of MEA
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cell line development market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global cell line development market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
3. Research Methodology
4. Cell Line Development - Market Landscape
5. Global Cell Line Development Market - Key Market Dynamics
6. Cell Line Development Market - Global Analysis
7. Cell Line Development Market - Revenue and Forecasts to 2027 - Type
8. Cell Line Development Market Analysis and Forecasts to 2027 - Product
9. Cell Line Development Market Analysis and Forecasts to 2027 - Application
10. Cell Line Development Market Revenue and Forecast to 2027 - Geographical Analysis
11. Impact Of COVID-19 Pandemic on Global Cell Line Development Market
12. Cell Line Development Market - Industry Landscape
13. Cell Line Development Market- Key Company Profiles
14. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Selexis SA (JSR Corporation)
- BioFactura, Inc.
- Corning Incorporated
- Sartorius AG
- Lonza
- GENERAL ELECTRIC
- LakePharma, Inc.
- WuXi AppTec Group